BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 20804548)

  • 1. Relative quantification of PIK3CA gene expression level in fine-needle aspiration biopsy thyroid specimens collected from patients with papillary thyroid carcinoma and non-toxic goitre by real-time RT-PCR.
    Wojciechowska-Durczyńska K; Krawczyk-Rusiecka K; Cyniak-Magierska A; Zygmunt A; Gałecka E; Lewiński A
    Thyroid Res; 2010 Aug; 3(1):5. PubMed ID: 20804548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is the PIK3CA gene expression level in FNAB washouts equivalent to that in postoperative tissue specimens of papillary thyroid carcinoma?
    Wojciechowska-Durczynska K; Krawczyk-Rusiecka K; Cyniak-Magierska A; Zygmunt A; Dedecjus M; Lewinski A
    Neuro Endocrinol Lett; 2011; 32(1):59-63. PubMed ID: 21407159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of correlation between the process of thyroid fibrosis and TGFB1 gene expression level in fine-needle aspiration biopsy (FNAB) thyroid specimens collected from patients with Hashimoto's thyroiditis and non-toxic goitre.
    Cyniak-Magierska A; Januszkiewicz-Caulier J; Brzeziańska E; Lewiński A
    Exp Clin Endocrinol Diabetes; 2010 Jul; 118(7):420-6. PubMed ID: 20191437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COX-2 expression in papillary thyroid carcinoma (PTC) in cytological material obtained by fine needle aspiration biopsy (FNAB).
    Krawczyk-Rusiecka K; Wojciechowska-Durczyńska K; Cyniak-Magierska A; Adamczewski Z; Gałecka E; Lewiński A
    Thyroid Res; 2011 Jan; 4(1):3. PubMed ID: 21214962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathological analysis of papillary thyroid cancer with PIK3CA alterations in a Middle Eastern population.
    Abubaker J; Jehan Z; Bavi P; Sultana M; Al-Harbi S; Ibrahim M; Al-Nuaim A; Ahmed M; Amin T; Al-Fehaily M; Al-Sanea O; Al-Dayel F; Uddin S; Al-Kuraya KS
    J Clin Endocrinol Metab; 2008 Feb; 93(2):611-8. PubMed ID: 18000091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of cyclooxygenase-1 and 2 gene expression levels in chronic autoimmune thyroiditis, papillary thyroid carcinoma and nontoxic nodular goitre.
    Krawczyk-Rusiecka K; Wojciechowska-Durczynska K; Cyniak-Magierska A; Zygmunt A; Lewinski A
    Thyroid Res; 2014; 7(1):10. PubMed ID: 25587354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression Levels of miR-30a-5p in Papillary Thyroid Carcinoma: A Comparison Between Serum and Fine Needle Aspiration Biopsy Samples.
    Igci YZ; Ozkaya M; Korkmaz H; Bozgeyik E; Bayraktar R; Ulasli M; Erkilic S; Eraydin A; Oztuzcu S
    Genet Test Mol Biomarkers; 2015 Aug; 19(8):418-23. PubMed ID: 26047355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of phosphoinositide 3-kinase subunits in chronic thyroiditis.
    Wojciechowska-Durczynska K; Krawczyk-Rusiecka K; Cyniak-Magierska A; Zygmunt A; Sporny S; Lewinski A
    Thyroid Res; 2012 Dec; 5(1):22. PubMed ID: 23259526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of RET/PTC1 and RET/PTC3 rearrangements in fine-needle aspiration biopsy specimens collected from patients with Hashimoto's thyroiditis.
    Cyniak-Magierska A; Wojciechowska-Durczyńska K; Krawczyk-Rusiecka K; Zygmunt A; Lewiński A
    Thyroid Res; 2011 Jan; 4(1):5. PubMed ID: 21219595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of cyclin D1 gene expression as a prognostic factor in benign and malignant thyroid lesions.
    Brzeziańska E; Cyniak-Magierska A; Sporny S; Pastuszak-Lewandoska D; Lewiński A
    Neuro Endocrinol Lett; 2007 Aug; 28(4):341-50. PubMed ID: 17693985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Follicular cell (papillary and follicular) thyroid carcinoma, genetic inheritance, and molecular diagnostic markers].
    Kazubskaia TP; Kozlova VM; Kondrat'eva TT; Pavlovskaia AI; Marakhonov AV; Baranova AV; Ivanova NI; Stepanova AA; Poliakov AV; Belev NF; Brzhezovskiĭ VZh
    Arkh Patol; 2014; 76(5):3-12. PubMed ID: 25543402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Value of immunohistochemistry in the detection of BRAF(V600E) mutations in fine-needle aspiration biopsies of papillary thyroid carcinoma.
    Zimmermann AK; Camenisch U; Rechsteiner MP; Bode-Lesniewska B; Rössle M
    Cancer Cytopathol; 2014 Jan; 122(1):48-58. PubMed ID: 24039206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FNAB of benign thyroid nodules with papillary hyperplasia: a cytological and histological evaluation.
    Pusztaszeri MP; Krane JF; Cibas ES; Daniels G; Faquin WC
    Cancer Cytopathol; 2014 Sep; 122(9):666-77. PubMed ID: 24891128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased expression of PIN1 gene in papillary thyroid carcinoma.
    Lewiński A; Brzeziańska E; Czarnecka K; Latek J; Koptas W; Cyniak-Magierska A
    Thyroid Res; 2011 Jan; 4(1):4. PubMed ID: 21219594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bethesda classification is a valuable guide for fine needle aspiration reports and highly predictive especially for diagnosing aggressive variants of papillary thyroid carcinoma.
    Evranos B; Polat SB; Baser H; Ozdemir D; Kilicarslan A; Yalcin A; Ersoy R; Cakir B
    Cytopathology; 2017 Aug; 28(4):259-267. PubMed ID: 27666595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction of false-negative papillary thyroid carcinomas by the routine analysis of BRAF(T1799A) mutation on fine-needle aspiration biopsy specimens: a prospective study of 814 thyroid FNAB patients.
    Cañadas-Garre M; Becerra-Massare P; López de la Torre-Casares M; Villar-del Moral J; Céspedes-Mas S; Vílchez-Joya R; Muros-de Fuentes T; García-Calvente C; Piédrola-Maroto G; López-Nevot MA; Montes-Ramírez R; Llamas-Elvira JM
    Ann Surg; 2012 May; 255(5):986-92. PubMed ID: 22504197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thyroglobulin Determination in Fine Needle Aspiration Biopsy Washout of Suspicious Lymph Nodes in Thyroid Carcinoma Follow up.
    Achille G; Garrisi VM; Russo S; Guastamacchia E; Giagulli VA; Schirosi L; Daniele A; Tufaro A; Cafagna V; Centrone M; Simone G; Abbate I; Triggiani V
    Endocr Metab Immune Disord Drug Targets; 2017; 17(3):213-218. PubMed ID: 28558632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic alterations in the RAS/RAF/mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt signaling pathways in the follicular variant of papillary thyroid carcinoma.
    Santarpia L; Myers JN; Sherman SI; Trimarchi F; Clayman GL; El-Naggar AK
    Cancer; 2010 Jun; 116(12):2974-83. PubMed ID: 20564403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of BRAF, NRAS, KRAS mutations as markers for the detection of papillary thyroid cancer from FNAB specimens by pyrosequencing analysis.
    Park SJ; Sun JY; Hong K; Kwak JY; Kim EK; Chung WY; Choi JR
    Clin Chem Lab Med; 2013 Aug; 51(8):1673-80. PubMed ID: 23585181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Papillary thyroid carcinoma: an easy fine needle aspiration biopsy diagnosis?
    Dušková J; Tretiník P
    Acta Cytol; 2011; 55(2):120-30. PubMed ID: 21325795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.